RNCS Free Assessment
Service 6

India Registration

India is one of the fastest-growing medical device markets in the world, and since 2022 every device sold there needs to sit inside a licensing system. For many manufacturers the difficulty is not the science. It is knowing which form, which authority and which document goes where, and getting it right the first time.

Get Your Free Regulatory AssessmentAdditional topics on India registrationLast reviewed: November 2026

Classification: Where Every CDSCO Application Starts

Under the Medical Devices Rules, 2017, Central Drugs Standard Control Organization (CDSCO) classifies every medical device and IVD into one of four risk-based categories:

  • Class A (low risk)
  • Class B (low–moderate risk)
  • Class C (moderate–high risk)
  • Class D (high risk)

Correct classification is extremely important, as the registration process, timeline, and document requirements all depend on the device class — it determines which licensing form applies, whether a Clinical Evaluation Report is required, and how likely the device is to face a facility inspection.

Getting classification right at the outset is the single most important step in the entire registration process, as it shapes every requirement that follows.

India Pathway at a Glance

RouteApplication / LicenceAuthorityIndicative timeline
Import (foreign manufacturer)MD-14 → MD-15CDSCO (Central Licensing Authority)Up to 9 months under the Rules
Manufacture Class A/BMD-3 → MD-5State Licensing Authority (audit by notified body)3–6 months
Manufacture Class C/DMD-7 → MD-9CDSCO6–9 months (inspection likely)
Test licence (samples for testing/evaluation)MD-16 → MD-17 (import); MD-12 → MD-13 (manufacture)CDSCO1–2 months
Clinical investigationMD-22 → MD-23CDSCOUp to 90 days

Import License – Form MD-14 & MD-15

Foreign manufacturers seeking to import medical devices into India must obtain an import license through a two-stage process. Form MD-14 is the application submitted by the Indian Authorized Agent through the CDSCO SUGAM portal, requesting the import license, while Form MD-15 is the actual license CDSCO issues once the MD-14 application is approved — the legal document that allows the device to be imported and sold in India.

In practice, the Authorized Agent matters more than most manufacturers expect. The agent signs the application, receives CDSCO communication and holds a Power of Attorney with an undertaking from you, authenticated in India or apostilled in your country. Choose an agent you trust, because they will be the face of your product to the regulator.

Because government fees and documentation requirements are charged per site and per distinct device, and vary by class, we help ensure your application is scoped correctly from the outset to avoid rework.

Device Master File (DMF) & Plant Master File (PMF) Preparation

A well-organized Device Master File (DMF) and Plant Master File (PMF) form the technical backbone of any CDSCO import license application. CDSCO's MD-14 checklist lists the categories of Device Master File evidence, and applicants are also expected to provide the latest competent-authority inspection or audit report from the previous three years, where available.

Both files follow formats set out in the Fourth Schedule of the Rules. The PMF describes the manufacturing site and its quality system. The DMF describes the device itself, from the executive summary and design through to verification, validation, labelling and release.

A well-aligned dossier can meaningfully reduce preventable regulatory queries and approval delays.

Manufacturing License – Form MD-5 & Form MD-9

Domestic manufacturers of Class A and B devices apply on Form MD-3 and receive a licence on Form MD-5 from the State Licensing Authority, after an audit by a CDSCO-registered notified body. Manufacturers of Class C and D devices apply on Form MD-7 and receive a licence on Form MD-9 from CDSCO, usually after a site inspection. We guide you through the QMS (Fifth Schedule), Device Master File, Plant Master File and inspection readiness for both routes.

Whether you're establishing new manufacturing operations in India or expanding existing ones, we help you navigate the licensing requirements specific to domestic production. This route carries its own documentation and inspection requirements, distinct from import licensing.

Clinical Evaluation Report (CER)

For Class C and D devices, a Clinical Evaluation Report is typically mandatory, and these higher-risk classes also face stricter eligibility criteria and a greater likelihood of overseas manufacturing site inspection, with CDSCO able to request a Medical Device Advisory Committee (MDAC) review before granting a license.

Strong clinical evidence is particularly critical for higher-risk devices, where CDSCO applies greater scrutiny throughout the review process.

Post-Approval Changes & License Retention

An MD-15 import license generally remains valid indefinitely, provided a retention fee is paid periodically (typically every five years) to keep the license active. Beyond retention, any changes to the device, manufacturer, or manufacturing site after approval must be reported to CDSCO as post-approval changes, ensuring the registration remains accurate and current.

Two practical points. The five-year clock runs from the date the base MD-15 was first issued, not from later endorsements, and the retention fee is set per site and per device. Missing the date can lead to penalties and, eventually, suspension or cancellation of the licence, so we suggest starting preparation well ahead.

Ongoing retention and change management support helps ensure your import license stays valid without unexpected lapses.

Query & Deficiency Letter Management

The CDSCO review process typically involves one or more deficiency letters, requiring applicants to respond within a defined window (commonly 7–14 days) to keep the application active and progressing. Delayed or incomplete responses are a common cause of stalled applications.

Proactive, responsive query management is often the difference between a smooth approval and a prolonged review cycle — and it's a core part of how we support you throughout the process.

Why Work With Us

Regulatory specialists, not generalists: Our team works on CDSCO, FDA, EU MDR and SFDA files, so we can see how your India plan fits the rest of your global strategy.
One accountable team: Classification, dossier, agent coordination, SUGAM filing and query handling stay with the same people from start to finish.
Clear scoping up front: We confirm class, device grouping and sites before filing, because fees and documents follow from those choices.
Plain-language updates: You will know where the application stands and what CDSCO has asked, without needing to decode portal notices.
Support after approval: Retention dates, endorsements and changes are tracked so the licence does not lapse quietly.
Ready to Get Started?

Bringing a device to India is easier with a clear plan. Tell us what you make and where you stand, and we will help you confirm classification, choose the right route and prepare a dossier that is ready for review. Contact us for a no-obligation discussion of your CDSCO pathway.

Get Your Free Regulatory Assessment
Did you know?
  • An MD-15 import licence does not expire. It stays valid as long as the retention fee is paid every five years.
  • Approval from a GHTF-founding country (US, EU, UK, Canada, Australia, Japan) supports your application, but it does not replace a full CDSCO dossier.
  • A small clerical mismatch between certificates and the master files is one of the most common reasons for a query.
India Registration – Frequently Asked Questions
Who can apply for an import licence?

Only an Indian entity holding a valid licence or registration to sell/distribute medical devices (e.g., Form MD-42 registration or a wholesale licence) or a manufacturing licence can act as Authorized Agent and file Form MD-14 on behalf of the foreign manufacturer.

Is my CE or FDA approval enough?

Approval from a GHTF country (US, EU, UK, Canada, Australia, Japan) supports the application and may waive local clinical investigation for many devices, but a full CDSCO dossier is still required.

Does the MD-15 licence expire?

It remains valid as long as the retention fee is paid every five years.

How long does registration take?

Under the Rules, an import licence decision can take up to nine months, and manufacturing licences vary by class and inspection needs. The biggest controllable factor is a complete, consistent dossier.

View All FAQs →
Contact us today

Tell us about your device and target market. Our regulatory specialist, not a salesperson, will reply within one business day.

Get Your Free Regulatory Assessment